Global Inactivated Hepatitis A Vaccine Supply, Demand and Key Producers, 2024-2030

Description

The global Inactivated Hepatitis A Vaccine market size is expected to reach $ million by 2030, rising at a market growth of % CAGR during the forecast period (2024-2030).

Inactivated Hepatitis A Vaccine is a type of vaccine designed to protect against the Hepatitis A virus. Hepatitis A is a viral infection that primarily affects the liver and is usually spread through contaminated food or water. The inactivated Hepatitis A vaccine is a preventive measure that helps the immune system recognize and fight the virus.

This report studies the global Inactivated Hepatitis A Vaccine production, demand, key manufacturers, and key regions.

This report is a detailed and comprehensive analysis of the world market for Inactivated Hepatitis A Vaccine, and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2023 as the base year. This report explores demand trends and competition, as well as details the characteristics of Inactivated Hepatitis A Vaccine that contribute to its increasing demand across many markets.

Highlights and key features of the study
Global Inactivated Hepatitis A Vaccine total production and demand, 2019-2030, (K Units)
Global Inactivated Hepatitis A Vaccine total production value, 2019-2030, (USD Million)
Global Inactivated Hepatitis A Vaccine production by region & country, production, value, CAGR, 2019-2030, (USD Million) & (K Units)
Global Inactivated Hepatitis A Vaccine consumption by region & country, CAGR, 2019-2030 & (K Units)
U.S. VS China: Inactivated Hepatitis A Vaccine domestic production, consumption, key domestic manufacturers and share
Global Inactivated Hepatitis A Vaccine production by manufacturer, production, price, value and market share 2019-2024, (USD Million) & (K Units)
Global Inactivated Hepatitis A Vaccine production by Type, production, value, CAGR, 2019-2030, (USD Million) & (K Units)
Global Inactivated Hepatitis A Vaccine production by Application production, value, CAGR, 2019-2030, (USD Million) & (K Units).

This reports profiles key players in the global Inactivated Hepatitis A Vaccine market based on the following parameters – company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Hualan Vaccine, SINOVAC, GSK, Merck, Sanofi, KM Biologics, IMBCAMS, AIM Vaccine and AIM Action, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Inactivated Hepatitis A Vaccine market.

Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2019-2030 by year with 2023 as the base year, 2024 as the estimate year, and 2025-2030 as the forecast year.

Global Inactivated Hepatitis A Vaccine Market, By Region:
    United States
    China
    Europe
    Japan
    South Korea
    ASEAN
    India
    Rest of World

Global Inactivated Hepatitis A Vaccine Market, Segmentation by Type
    1.0ml
    0.5ml

Global Inactivated Hepatitis A Vaccine Market, Segmentation by Application
    Hospital
    Clinic

Companies Profiled:
    Hualan Vaccine
    SINOVAC
    GSK
    Merck
    Sanofi
    KM Biologics
    IMBCAMS
    AIM Vaccine
    AIM Action

Key Questions Answered
1. How big is the global Inactivated Hepatitis A Vaccine market?
2. What is the demand of the global Inactivated Hepatitis A Vaccine market?
3. What is the year over year growth of the global Inactivated Hepatitis A Vaccine market?
4. What is the production and production value of the global Inactivated Hepatitis A Vaccine market?
5. Who are the key producers in the global Inactivated Hepatitis A Vaccine market?

Table of Contents

1 Supply Summary
    1.1 Inactivated Hepatitis A Vaccine Introduction
    1.2 World Inactivated Hepatitis A Vaccine Supply & Forecast
        1.2.1 World Inactivated Hepatitis A Vaccine Production Value (2019 & 2023 & 2030)
        1.2.2 World Inactivated Hepatitis A Vaccine Production (2019-2030)
        1.2.3 World Inactivated Hepatitis A Vaccine Pricing Trends (2019-2030)
    1.3 World Inactivated Hepatitis A Vaccine Production by Region (Based on Production Site)
        1.3.1 World Inactivated Hepatitis A Vaccine Production Value by Region (2019-2030)
        1.3.2 World Inactivated Hepatitis A Vaccine Production by Region (2019-2030)
        1.3.3 World Inactivated Hepatitis A Vaccine Average Price by Region (2019-2030)
        1.3.4 North America Inactivated Hepatitis A Vaccine Production (2019-2030)
        1.3.5 Europe Inactivated Hepatitis A Vaccine Production (2019-2030)
        1.3.6 China Inactivated Hepatitis A Vaccine Production (2019-2030)
        1.3.7 Japan Inactivated Hepatitis A Vaccine Production (2019-2030)
    1.4 Market Drivers, Restraints and Trends
        1.4.1 Inactivated Hepatitis A Vaccine Market Drivers
        1.4.2 Factors Affecting Demand
        1.4.3 Inactivated Hepatitis A Vaccine Major Market Trends

2 Demand Summary
    2.1 World Inactivated Hepatitis A Vaccine Demand (2019-2030)
    2.2 World Inactivated Hepatitis A Vaccine Consumption by Region
        2.2.1 World Inactivated Hepatitis A Vaccine Consumption by Region (2019-2024)
        2.2.2 World Inactivated Hepatitis A Vaccine Consumption Forecast by Region (2025-2030)
    2.3 United States Inactivated Hepatitis A Vaccine Consumption (2019-2030)
    2.4 China Inactivated Hepatitis A Vaccine Consumption (2019-2030)
    2.5 Europe Inactivated Hepatitis A Vaccine Consumption (2019-2030)
    2.6 Japan Inactivated Hepatitis A Vaccine Consumption (2019-2030)
    2.7 South Korea Inactivated Hepatitis A Vaccine Consumption (2019-2030)
    2.8 ASEAN Inactivated Hepatitis A Vaccine Consumption (2019-2030)
    2.9 India Inactivated Hepatitis A Vaccine Consumption (2019-2030)

3 World Inactivated Hepatitis A Vaccine Manufacturers Competitive Analysis
    3.1 World Inactivated Hepatitis A Vaccine Production Value by Manufacturer (2019-2024)
    3.2 World Inactivated Hepatitis A Vaccine Production by Manufacturer (2019-2024)
    3.3 World Inactivated Hepatitis A Vaccine Average Price by Manufacturer (2019-2024)
    3.4 Inactivated Hepatitis A Vaccine Company Evaluation Quadrant
    3.5 Industry Rank and Concentration Rate (CR)
        3.5.1 Global Inactivated Hepatitis A Vaccine Industry Rank of Major Manufacturers
        3.5.2 Global Concentration Ratios (CR4) for Inactivated Hepatitis A Vaccine in 2023
        3.5.3 Global Concentration Ratios (CR8) for Inactivated Hepatitis A Vaccine in 2023
    3.6 Inactivated Hepatitis A Vaccine Market: Overall Company Footprint Analysis
        3.6.1 Inactivated Hepatitis A Vaccine Market: Region Footprint
        3.6.2 Inactivated Hepatitis A Vaccine Market: Company Product Type Footprint
        3.6.3 Inactivated Hepatitis A Vaccine Market: Company Product Application Footprint
    3.7 Competitive Environment
        3.7.1 Historical Structure of the Industry
        3.7.2 Barriers of Market Entry
        3.7.3 Factors of Competition
    3.8 New Entrant and Capacity Expansion Plans
    3.9 Mergers, Acquisition, Agreements, and Collaborations

4 United States VS China VS Rest of the World
    4.1 United States VS China: Inactivated Hepatitis A Vaccine Production Value Comparison
        4.1.1 United States VS China: Inactivated Hepatitis A Vaccine Production Value Comparison (2019 & 2023 & 2030)
        4.1.2 United States VS China: Inactivated Hepatitis A Vaccine Production Value Market Share Comparison (2019 & 2023 & 2030)
    4.2 United States VS China: Inactivated Hepatitis A Vaccine Production Comparison
        4.2.1 United States VS China: Inactivated Hepatitis A Vaccine Production Comparison (2019 & 2023 & 2030)
        4.2.2 United States VS China: Inactivated Hepatitis A Vaccine Production Market Share Comparison (2019 & 2023 & 2030)
    4.3 United States VS China: Inactivated Hepatitis A Vaccine Consumption Comparison
        4.3.1 United States VS China: Inactivated Hepatitis A Vaccine Consumption Comparison (2019 & 2023 & 2030)
        4.3.2 United States VS China: Inactivated Hepatitis A Vaccine Consumption Market Share Comparison (2019 & 2023 & 2030)
    4.4 United States Based Inactivated Hepatitis A Vaccine Manufacturers and Market Share, 2019-2024
        4.4.1 United States Based Inactivated Hepatitis A Vaccine Manufacturers, Headquarters and Production Site (States, Country)
        4.4.2 United States Based Manufacturers Inactivated Hepatitis A Vaccine Production Value (2019-2024)
        4.4.3 United States Based Manufacturers Inactivated Hepatitis A Vaccine Production (2019-2024)
    4.5 China Based Inactivated Hepatitis A Vaccine Manufacturers and Market Share
        4.5.1 China Based Inactivated Hepatitis A Vaccine Manufacturers, Headquarters and Production Site (Province, Country)
        4.5.2 China Based Manufacturers Inactivated Hepatitis A Vaccine Production Value (2019-2024)
        4.5.3 China Based Manufacturers Inactivated Hepatitis A Vaccine Production (2019-2024)
    4.6 Rest of World Based Inactivated Hepatitis A Vaccine Manufacturers and Market Share, 2019-2024
        4.6.1 Rest of World Based Inactivated Hepatitis A Vaccine Manufacturers, Headquarters and Production Site (State, Country)
        4.6.2 Rest of World Based Manufacturers Inactivated Hepatitis A Vaccine Production Value (2019-2024)
        4.6.3 Rest of World Based Manufacturers Inactivated Hepatitis A Vaccine Production (2019-2024)

5 Market Analysis by Type
    5.1 World Inactivated Hepatitis A Vaccine Market Size Overview by Type: 2019 VS 2023 VS 2030
    5.2 Segment Introduction by Type
        5.2.1 1.0ml
        5.2.2 0.5ml
    5.3 Market Segment by Type
        5.3.1 World Inactivated Hepatitis A Vaccine Production by Type (2019-2030)
        5.3.2 World Inactivated Hepatitis A Vaccine Production Value by Type (2019-2030)
        5.3.3 World Inactivated Hepatitis A Vaccine Average Price by Type (2019-2030)

6 Market Analysis by Application
    6.1 World Inactivated Hepatitis A Vaccine Market Size Overview by Application: 2019 VS 2023 VS 2030
    6.2 Segment Introduction by Application
        6.2.1 Hospital
        6.2.2 Clinic
    6.3 Market Segment by Application
        6.3.1 World Inactivated Hepatitis A Vaccine Production by Application (2019-2030)
        6.3.2 World Inactivated Hepatitis A Vaccine Production Value by Application (2019-2030)
        6.3.3 World Inactivated Hepatitis A Vaccine Average Price by Application (2019-2030)

7 Company Profiles
    7.1 Hualan Vaccine
        7.1.1 Hualan Vaccine Details
        7.1.2 Hualan Vaccine Major Business
        7.1.3 Hualan Vaccine Inactivated Hepatitis A Vaccine Product and Services
        7.1.4 Hualan Vaccine Inactivated Hepatitis A Vaccine Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.1.5 Hualan Vaccine Recent Developments/Updates
        7.1.6 Hualan Vaccine Competitive Strengths & Weaknesses
    7.2 SINOVAC
        7.2.1 SINOVAC Details
        7.2.2 SINOVAC Major Business
        7.2.3 SINOVAC Inactivated Hepatitis A Vaccine Product and Services
        7.2.4 SINOVAC Inactivated Hepatitis A Vaccine Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.2.5 SINOVAC Recent Developments/Updates
        7.2.6 SINOVAC Competitive Strengths & Weaknesses
    7.3 GSK
        7.3.1 GSK Details
        7.3.2 GSK Major Business
        7.3.3 GSK Inactivated Hepatitis A Vaccine Product and Services
        7.3.4 GSK Inactivated Hepatitis A Vaccine Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.3.5 GSK Recent Developments/Updates
        7.3.6 GSK Competitive Strengths & Weaknesses
    7.4 Merck
        7.4.1 Merck Details
        7.4.2 Merck Major Business
        7.4.3 Merck Inactivated Hepatitis A Vaccine Product and Services
        7.4.4 Merck Inactivated Hepatitis A Vaccine Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.4.5 Merck Recent Developments/Updates
        7.4.6 Merck Competitive Strengths & Weaknesses
    7.5 Sanofi
        7.5.1 Sanofi Details
        7.5.2 Sanofi Major Business
        7.5.3 Sanofi Inactivated Hepatitis A Vaccine Product and Services
        7.5.4 Sanofi Inactivated Hepatitis A Vaccine Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.5.5 Sanofi Recent Developments/Updates
        7.5.6 Sanofi Competitive Strengths & Weaknesses
    7.6 KM Biologics
        7.6.1 KM Biologics Details
        7.6.2 KM Biologics Major Business
        7.6.3 KM Biologics Inactivated Hepatitis A Vaccine Product and Services
        7.6.4 KM Biologics Inactivated Hepatitis A Vaccine Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.6.5 KM Biologics Recent Developments/Updates
        7.6.6 KM Biologics Competitive Strengths & Weaknesses
    7.7 IMBCAMS
        7.7.1 IMBCAMS Details
        7.7.2 IMBCAMS Major Business
        7.7.3 IMBCAMS Inactivated Hepatitis A Vaccine Product and Services
        7.7.4 IMBCAMS Inactivated Hepatitis A Vaccine Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.7.5 IMBCAMS Recent Developments/Updates
        7.7.6 IMBCAMS Competitive Strengths & Weaknesses
    7.8 AIM Vaccine
        7.8.1 AIM Vaccine Details
        7.8.2 AIM Vaccine Major Business
        7.8.3 AIM Vaccine Inactivated Hepatitis A Vaccine Product and Services
        7.8.4 AIM Vaccine Inactivated Hepatitis A Vaccine Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.8.5 AIM Vaccine Recent Developments/Updates
        7.8.6 AIM Vaccine Competitive Strengths & Weaknesses
    7.9 AIM Action
        7.9.1 AIM Action Details
        7.9.2 AIM Action Major Business
        7.9.3 AIM Action Inactivated Hepatitis A Vaccine Product and Services
        7.9.4 AIM Action Inactivated Hepatitis A Vaccine Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.9.5 AIM Action Recent Developments/Updates
        7.9.6 AIM Action Competitive Strengths & Weaknesses

8 Industry Chain Analysis
    8.1 Inactivated Hepatitis A Vaccine Industry Chain
    8.2 Inactivated Hepatitis A Vaccine Upstream Analysis
        8.2.1 Inactivated Hepatitis A Vaccine Core Raw Materials
        8.2.2 Main Manufacturers of Inactivated Hepatitis A Vaccine Core Raw Materials
    8.3 Midstream Analysis
    8.4 Downstream Analysis
    8.5 Inactivated Hepatitis A Vaccine Production Mode
    8.6 Inactivated Hepatitis A Vaccine Procurement Model
    8.7 Inactivated Hepatitis A Vaccine Industry Sales Model and Sales Channels
        8.7.1 Inactivated Hepatitis A Vaccine Sales Model
        8.7.2 Inactivated Hepatitis A Vaccine Typical Customers

9 Research Findings and Conclusion

10 Appendix
    10.1 Methodology
    10.2 Research Process and Data Source
    10.3 Disclaimer

Table of Figures

List of Tables
    Table 1. World Inactivated Hepatitis A Vaccine Production Value by Region (2019, 2023 and 2030) & (USD Million)
    Table 2. World Inactivated Hepatitis A Vaccine Production Value by Region (2019-2024) & (USD Million)
    Table 3. World Inactivated Hepatitis A Vaccine Production Value by Region (2025-2030) & (USD Million)
    Table 4. World Inactivated Hepatitis A Vaccine Production Value Market Share by Region (2019-2024)
    Table 5. World Inactivated Hepatitis A Vaccine Production Value Market Share by Region (2025-2030)
    Table 6. World Inactivated Hepatitis A Vaccine Production by Region (2019-2024) & (K Units)
    Table 7. World Inactivated Hepatitis A Vaccine Production by Region (2025-2030) & (K Units)
    Table 8. World Inactivated Hepatitis A Vaccine Production Market Share by Region (2019-2024)
    Table 9. World Inactivated Hepatitis A Vaccine Production Market Share by Region (2025-2030)
    Table 10. World Inactivated Hepatitis A Vaccine Average Price by Region (2019-2024) & (US$/Unit)
    Table 11. World Inactivated Hepatitis A Vaccine Average Price by Region (2025-2030) & (US$/Unit)
    Table 12. Inactivated Hepatitis A Vaccine Major Market Trends
    Table 13. World Inactivated Hepatitis A Vaccine Consumption Growth Rate Forecast by Region (2019 & 2023 & 2030) & (K Units)
    Table 14. World Inactivated Hepatitis A Vaccine Consumption by Region (2019-2024) & (K Units)
    Table 15. World Inactivated Hepatitis A Vaccine Consumption Forecast by Region (2025-2030) & (K Units)
    Table 16. World Inactivated Hepatitis A Vaccine Production Value by Manufacturer (2019-2024) & (USD Million)
    Table 17. Production Value Market Share of Key Inactivated Hepatitis A Vaccine Producers in 2023
    Table 18. World Inactivated Hepatitis A Vaccine Production by Manufacturer (2019-2024) & (K Units)
    Table 19. Production Market Share of Key Inactivated Hepatitis A Vaccine Producers in 2023
    Table 20. World Inactivated Hepatitis A Vaccine Average Price by Manufacturer (2019-2024) & (US$/Unit)
    Table 21. Global Inactivated Hepatitis A Vaccine Company Evaluation Quadrant
    Table 22. World Inactivated Hepatitis A Vaccine Industry Rank of Major Manufacturers, Based on Production Value in 2023
    Table 23. Head Office and Inactivated Hepatitis A Vaccine Production Site of Key Manufacturer
    Table 24. Inactivated Hepatitis A Vaccine Market: Company Product Type Footprint
    Table 25. Inactivated Hepatitis A Vaccine Market: Company Product Application Footprint
    Table 26. Inactivated Hepatitis A Vaccine Competitive Factors
    Table 27. Inactivated Hepatitis A Vaccine New Entrant and Capacity Expansion Plans
    Table 28. Inactivated Hepatitis A Vaccine Mergers & Acquisitions Activity
    Table 29. United States VS China Inactivated Hepatitis A Vaccine Production Value Comparison, (2019 & 2023 & 2030) & (USD Million)
    Table 30. United States VS China Inactivated Hepatitis A Vaccine Production Comparison, (2019 & 2023 & 2030) & (K Units)
    Table 31. United States VS China Inactivated Hepatitis A Vaccine Consumption Comparison, (2019 & 2023 & 2030) & (K Units)
    Table 32. United States Based Inactivated Hepatitis A Vaccine Manufacturers, Headquarters and Production Site (States, Country)
    Table 33. United States Based Manufacturers Inactivated Hepatitis A Vaccine Production Value, (2019-2024) & (USD Million)
    Table 34. United States Based Manufacturers Inactivated Hepatitis A Vaccine Production Value Market Share (2019-2024)
    Table 35. United States Based Manufacturers Inactivated Hepatitis A Vaccine Production (2019-2024) & (K Units)
    Table 36. United States Based Manufacturers Inactivated Hepatitis A Vaccine Production Market Share (2019-2024)
    Table 37. China Based Inactivated Hepatitis A Vaccine Manufacturers, Headquarters and Production Site (Province, Country)
    Table 38. China Based Manufacturers Inactivated Hepatitis A Vaccine Production Value, (2019-2024) & (USD Million)
    Table 39. China Based Manufacturers Inactivated Hepatitis A Vaccine Production Value Market Share (2019-2024)
    Table 40. China Based Manufacturers Inactivated Hepatitis A Vaccine Production (2019-2024) & (K Units)
    Table 41. China Based Manufacturers Inactivated Hepatitis A Vaccine Production Market Share (2019-2024)
    Table 42. Rest of World Based Inactivated Hepatitis A Vaccine Manufacturers, Headquarters and Production Site (States, Country)
    Table 43. Rest of World Based Manufacturers Inactivated Hepatitis A Vaccine Production Value, (2019-2024) & (USD Million)
    Table 44. Rest of World Based Manufacturers Inactivated Hepatitis A Vaccine Production Value Market Share (2019-2024)
    Table 45. Rest of World Based Manufacturers Inactivated Hepatitis A Vaccine Production (2019-2024) & (K Units)
    Table 46. Rest of World Based Manufacturers Inactivated Hepatitis A Vaccine Production Market Share (2019-2024)
    Table 47. World Inactivated Hepatitis A Vaccine Production Value by Type, (USD Million), 2019 & 2023 & 2030
    Table 48. World Inactivated Hepatitis A Vaccine Production by Type (2019-2024) & (K Units)
    Table 49. World Inactivated Hepatitis A Vaccine Production by Type (2025-2030) & (K Units)
    Table 50. World Inactivated Hepatitis A Vaccine Production Value by Type (2019-2024) & (USD Million)
    Table 51. World Inactivated Hepatitis A Vaccine Production Value by Type (2025-2030) & (USD Million)
    Table 52. World Inactivated Hepatitis A Vaccine Average Price by Type (2019-2024) & (US$/Unit)
    Table 53. World Inactivated Hepatitis A Vaccine Average Price by Type (2025-2030) & (US$/Unit)
    Table 54. World Inactivated Hepatitis A Vaccine Production Value by Application, (USD Million), 2019 & 2023 & 2030
    Table 55. World Inactivated Hepatitis A Vaccine Production by Application (2019-2024) & (K Units)
    Table 56. World Inactivated Hepatitis A Vaccine Production by Application (2025-2030) & (K Units)
    Table 57. World Inactivated Hepatitis A Vaccine Production Value by Application (2019-2024) & (USD Million)
    Table 58. World Inactivated Hepatitis A Vaccine Production Value by Application (2025-2030) & (USD Million)
    Table 59. World Inactivated Hepatitis A Vaccine Average Price by Application (2019-2024) & (US$/Unit)
    Table 60. World Inactivated Hepatitis A Vaccine Average Price by Application (2025-2030) & (US$/Unit)
    Table 61. Hualan Vaccine Basic Information, Manufacturing Base and Competitors
    Table 62. Hualan Vaccine Major Business
    Table 63. Hualan Vaccine Inactivated Hepatitis A Vaccine Product and Services
    Table 64. Hualan Vaccine Inactivated Hepatitis A Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
    Table 65. Hualan Vaccine Recent Developments/Updates
    Table 66. Hualan Vaccine Competitive Strengths & Weaknesses
    Table 67. SINOVAC Basic Information, Manufacturing Base and Competitors
    Table 68. SINOVAC Major Business
    Table 69. SINOVAC Inactivated Hepatitis A Vaccine Product and Services
    Table 70. SINOVAC Inactivated Hepatitis A Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
    Table 71. SINOVAC Recent Developments/Updates
    Table 72. SINOVAC Competitive Strengths & Weaknesses
    Table 73. GSK Basic Information, Manufacturing Base and Competitors
    Table 74. GSK Major Business
    Table 75. GSK Inactivated Hepatitis A Vaccine Product and Services
    Table 76. GSK Inactivated Hepatitis A Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
    Table 77. GSK Recent Developments/Updates
    Table 78. GSK Competitive Strengths & Weaknesses
    Table 79. Merck Basic Information, Manufacturing Base and Competitors
    Table 80. Merck Major Business
    Table 81. Merck Inactivated Hepatitis A Vaccine Product and Services
    Table 82. Merck Inactivated Hepatitis A Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
    Table 83. Merck Recent Developments/Updates
    Table 84. Merck Competitive Strengths & Weaknesses
    Table 85. Sanofi Basic Information, Manufacturing Base and Competitors
    Table 86. Sanofi Major Business
    Table 87. Sanofi Inactivated Hepatitis A Vaccine Product and Services
    Table 88. Sanofi Inactivated Hepatitis A Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
    Table 89. Sanofi Recent Developments/Updates
    Table 90. Sanofi Competitive Strengths & Weaknesses
    Table 91. KM Biologics Basic Information, Manufacturing Base and Competitors
    Table 92. KM Biologics Major Business
    Table 93. KM Biologics Inactivated Hepatitis A Vaccine Product and Services
    Table 94. KM Biologics Inactivated Hepatitis A Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
    Table 95. KM Biologics Recent Developments/Updates
    Table 96. KM Biologics Competitive Strengths & Weaknesses
    Table 97. IMBCAMS Basic Information, Manufacturing Base and Competitors
    Table 98. IMBCAMS Major Business
    Table 99. IMBCAMS Inactivated Hepatitis A Vaccine Product and Services
    Table 100. IMBCAMS Inactivated Hepatitis A Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
    Table 101. IMBCAMS Recent Developments/Updates
    Table 102. IMBCAMS Competitive Strengths & Weaknesses
    Table 103. AIM Vaccine Basic Information, Manufacturing Base and Competitors
    Table 104. AIM Vaccine Major Business
    Table 105. AIM Vaccine Inactivated Hepatitis A Vaccine Product and Services
    Table 106. AIM Vaccine Inactivated Hepatitis A Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
    Table 107. AIM Vaccine Recent Developments/Updates
    Table 108. AIM Action Basic Information, Manufacturing Base and Competitors
    Table 109. AIM Action Major Business
    Table 110. AIM Action Inactivated Hepatitis A Vaccine Product and Services
    Table 111. AIM Action Inactivated Hepatitis A Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
    Table 112. Global Key Players of Inactivated Hepatitis A Vaccine Upstream (Raw Materials)
    Table 113. Inactivated Hepatitis A Vaccine Typical Customers
    Table 114. Inactivated Hepatitis A Vaccine Typical Distributors
List of Figure
    Figure 1. Inactivated Hepatitis A Vaccine Picture
    Figure 2. World Inactivated Hepatitis A Vaccine Production Value: 2019 & 2023 & 2030, (USD Million)
    Figure 3. World Inactivated Hepatitis A Vaccine Production Value and Forecast (2019-2030) & (USD Million)
    Figure 4. World Inactivated Hepatitis A Vaccine Production (2019-2030) & (K Units)
    Figure 5. World Inactivated Hepatitis A Vaccine Average Price (2019-2030) & (US$/Unit)
    Figure 6. World Inactivated Hepatitis A Vaccine Production Value Market Share by Region (2019-2030)
    Figure 7. World Inactivated Hepatitis A Vaccine Production Market Share by Region (2019-2030)
    Figure 8. North America Inactivated Hepatitis A Vaccine Production (2019-2030) & (K Units)
    Figure 9. Europe Inactivated Hepatitis A Vaccine Production (2019-2030) & (K Units)
    Figure 10. China Inactivated Hepatitis A Vaccine Production (2019-2030) & (K Units)
    Figure 11. Japan Inactivated Hepatitis A Vaccine Production (2019-2030) & (K Units)
    Figure 12. Inactivated Hepatitis A Vaccine Market Drivers
    Figure 13. Factors Affecting Demand
    Figure 14. World Inactivated Hepatitis A Vaccine Consumption (2019-2030) & (K Units)
    Figure 15. World Inactivated Hepatitis A Vaccine Consumption Market Share by Region (2019-2030)
    Figure 16. United States Inactivated Hepatitis A Vaccine Consumption (2019-2030) & (K Units)
    Figure 17. China Inactivated Hepatitis A Vaccine Consumption (2019-2030) & (K Units)
    Figure 18. Europe Inactivated Hepatitis A Vaccine Consumption (2019-2030) & (K Units)
    Figure 19. Japan Inactivated Hepatitis A Vaccine Consumption (2019-2030) & (K Units)
    Figure 20. South Korea Inactivated Hepatitis A Vaccine Consumption (2019-2030) & (K Units)
    Figure 21. ASEAN Inactivated Hepatitis A Vaccine Consumption (2019-2030) & (K Units)
    Figure 22. India Inactivated Hepatitis A Vaccine Consumption (2019-2030) & (K Units)
    Figure 23. Producer Shipments of Inactivated Hepatitis A Vaccine by Manufacturer Revenue ($MM) and Market Share (%): 2023
    Figure 24. Global Four-firm Concentration Ratios (CR4) for Inactivated Hepatitis A Vaccine Markets in 2023
    Figure 25. Global Four-firm Concentration Ratios (CR8) for Inactivated Hepatitis A Vaccine Markets in 2023
    Figure 26. United States VS China: Inactivated Hepatitis A Vaccine Production Value Market Share Comparison (2019 & 2023 & 2030)
    Figure 27. United States VS China: Inactivated Hepatitis A Vaccine Production Market Share Comparison (2019 & 2023 & 2030)
    Figure 28. United States VS China: Inactivated Hepatitis A Vaccine Consumption Market Share Comparison (2019 & 2023 & 2030)
    Figure 29. United States Based Manufacturers Inactivated Hepatitis A Vaccine Production Market Share 2023
    Figure 30. China Based Manufacturers Inactivated Hepatitis A Vaccine Production Market Share 2023
    Figure 31. Rest of World Based Manufacturers Inactivated Hepatitis A Vaccine Production Market Share 2023
    Figure 32. World Inactivated Hepatitis A Vaccine Production Value by Type, (USD Million), 2019 & 2023 & 2030
    Figure 33. World Inactivated Hepatitis A Vaccine Production Value Market Share by Type in 2023
    Figure 34. 1.0ml
    Figure 35. 0.5ml
    Figure 36. World Inactivated Hepatitis A Vaccine Production Market Share by Type (2019-2030)
    Figure 37. World Inactivated Hepatitis A Vaccine Production Value Market Share by Type (2019-2030)
    Figure 38. World Inactivated Hepatitis A Vaccine Average Price by Type (2019-2030) & (US$/Unit)
    Figure 39. World Inactivated Hepatitis A Vaccine Production Value by Application, (USD Million), 2019 & 2023 & 2030
    Figure 40. World Inactivated Hepatitis A Vaccine Production Value Market Share by Application in 2023
    Figure 41. Hospital
    Figure 42. Clinic
    Figure 43. World Inactivated Hepatitis A Vaccine Production Market Share by Application (2019-2030)
    Figure 44. World Inactivated Hepatitis A Vaccine Production Value Market Share by Application (2019-2030)
    Figure 45. World Inactivated Hepatitis A Vaccine Average Price by Application (2019-2030) & (US$/Unit)
    Figure 46. Inactivated Hepatitis A Vaccine Industry Chain
    Figure 47. Inactivated Hepatitis A Vaccine Procurement Model
    Figure 48. Inactivated Hepatitis A Vaccine Sales Model
    Figure 49. Inactivated Hepatitis A Vaccine Sales Channels, Direct Sales, and Distribution
    Figure 50. Methodology
    Figure 51. Research Process and Data Source

Companies Mentioned

Hualan Vaccine
SINOVAC
GSK
Merck
Sanofi
KM Biologics
IMBCAMS
AIM Vaccine
AIM Action